Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when XOS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsXos raises $6M through registered direct offering at $5.50 per share
Filed June 5, 2026 · Period ending June 4, 2026 · ~1 min read
Key Changes
-
high
Xos sold 1,090,910 common shares to institutional investors at $5.50 per share, raising approximately $6 million in gross proceeds before fees and expenses.
Item 1.01 verify on EDGAR → -
high
The new share issuance dilutes existing shareholders by adding over 1 million shares to the outstanding share count at the $5.50 institutional purchase price.
Item 1.01 verify on EDGAR → -
medium
Placement agent Roth Capital Partners will receive 6.5% of gross proceeds (approximately $390,000) plus up to $75,000 in expenses, reducing net proceeds to roughly $5.5 million.
Item 1.01 verify on EDGAR →
Summary
Xos completed a $6 million capital raise on June 5, 2026, selling 1,090,910 common shares to institutional investors at $5.50 per share through a registered direct offering. The company used its existing shelf registration statement to execute the transaction, with Roth Capital Partners serving as exclusive placement agent.
For existing shareholders, this represents meaningful dilution as over 1 million new shares enter circulation. After deducting the 6.5% placement fee and expenses, Xos will net approximately $5.5 million. The $5.50 share price provides a reference point for how institutional investors valued the company at the time of the transaction.
Investors should monitor how Xos deploys these proceeds and whether the company requires additional capital raises in the near term. The use of a registered direct offering suggests urgency for capital, as this structure allows faster execution than traditional public offerings. Watch for disclosure of the specific use of proceeds in upcoming filings or earnings calls.
Section-by-Section Diff
Event · Item 9.01 — Financial Statements and Exhibits
Xos executed a securities purchase agreement and placement agency agreement on June 4, 2026, indicating a capital raise transaction.
Added in current filing · verify on EDGAR →
Securities Purchase Agreement, dated June 4, 2026, by and among Xos, Inc. and certain investors
Xos entered into a securities purchase agreement with investors on June 4, 2026. This indicates the company is raising capital through the sale of securities to investors. The specific terms, amount raised, and type of securities are not disclosed in this 8-K body but would be detailed in the attached exhibit.
Added in current filing · verify on EDGAR →
Placement Agency Agreement, dated June 4, 2026, by and among Xos, Inc. and Roth Capital Partners, LLC
Xos engaged Roth Capital Partners as placement agent for the capital raise transaction. Placement agents typically facilitate private placements of securities and receive fees based on the amount raised. This suggests the transaction is a private placement rather than a public offering.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Opinion of Proskauer Rose LLP
Proskauer Rose LLP provided a legal opinion, standard practice in securities transactions to opine on the validity and legal issuance of securities being sold. This is a procedural requirement for the capital raise transaction.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 8, 2026 · How we verify